UPDATE: Morgan Stanley Raises PT to $37 on Merck - Merck & Co (NYSE:MRK)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Morgan Stanley reiterates its Equal-weight rating on Merck (NYSE: MRK) and raises its price target to $37 (previously $34) as it extends model through 2020. Morgan Stanley says, "We raise our PT on MRK from $34 to $37, based on extending our model through 2020 and pushing IMPROVE-IT-driven Vytorin cliff from 2013 to 2014. We maintain 60% odds that IMPROVE-IT fails to show Vytorin is better than Zocor."MRK closed at $37.91 a share on Friday.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!